These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25851296)

  • 1. Recurrent idiopathic membranous glomerulonephritis after kidney transplantation and successful treatment with rituximab.
    Makhdoomi K; Abkhiz S; Noroozinia F; Mivefroshan A; Zeinali J; Jafari L; Jafari L; Saffarifard A
    Iran J Kidney Dis; 2015 Mar; 9(2):158-62. PubMed ID: 25851296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficiency of rituximab treatment for recurrence of membranous glomerulopathy after renal transplantation].
    Wéclawiak H; Ribes D; Modesto A; Kamar N; Durand D; Rostaing L
    Nephrol Ther; 2007 Apr; 3(2):65-8. PubMed ID: 17452303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome of renal transplantation in patients with idiopathic membranous glomerulonephritis (MN).
    Moroni G; Gallelli B; Quaglini S; Leoni A; Banfi G; Passerini P; Montagnino G; Messa P
    Nephrol Dial Transplant; 2010 Oct; 25(10):3408-15. PubMed ID: 20466669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent Membranous Nephropathy After Kidney Transplantation Associated With Phospholipase A2 Receptor and Successfully Treated With Rituximab: A Case Report.
    Ishiwatari A; Wakai S; Shirakawa H; Honda K
    Transplant Proc; 2018 Oct; 50(8):2565-2568. PubMed ID: 30316399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bortezomib as a Novel Approach to Early Recurrent Membranous Glomerulonephritis After Kidney Transplant Refractory to Combined Conventional Rituximab Therapy.
    Barbari A; Chehadi R; Kfoury Assouf H; Kamel G; Jaafar M; Abdallah A; Rizk S; Masri M
    Exp Clin Transplant; 2017 Jun; 15(3):350-354. PubMed ID: 28367758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effect of rituximab in the treatment of recurrent idiopathic membranous nephropathy after kidney transplantation.
    Sprangers B; Lefkowitz GI; Cohen SD; Stokes MB; Valeri A; Appel GB; Kunis CL
    Clin J Am Soc Nephrol; 2010 May; 5(5):790-7. PubMed ID: 20185599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relapse of membranous glomerulopathy after kidney transplantation: sustained remittance induced by rituximab.
    Weclawiak H; Ribes D; Guilbeau-Frugier C; Touchard G; Kamar N; Mehrenberger M; Modesto A; Rostaing L
    Clin Nephrol; 2008 May; 69(5):373-6. PubMed ID: 18538101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Ormond Disease and Idiopathic Membranous Glomerulonephritis by using Rituximab.
    Dedinská I; Svetlík D; Adamicova K; Machalekova K; Makovicky P; Jezikova A; Laca L; Miklusica J; Galajda P; Mokan M
    Iran J Kidney Dis; 2016 Sep; 10(5):332-335. PubMed ID: 27721233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-dose rituximab for recurrent glomerulonephritis post-renal transplant.
    Spinner ML; Bowman LJ; Horwedel TA; Delos Santos RB; Klein CL; Brennan DC
    Am J Nephrol; 2015; 41(1):37-47. PubMed ID: 25634230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathology and clinical features of early recurrent membranous glomerulonephritis.
    Rodriguez EF; Cosio FG; Nasr SH; Sethi S; Fidler ME; Stegall MD; Grande JP; Fervenza FC; Cornell LD
    Am J Transplant; 2012 Apr; 12(4):1029-38. PubMed ID: 22233329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab In The Treatment Of Refractory Idiopathic Membranous Nephropathy In Pakistani Population.
    Anjum N; Nabi Z; Alam MA
    J Ayub Med Coll Abbottabad; 2019; 31(2):265-268. PubMed ID: 31094128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab in primary membranous nephropathy: beyond a B-cell-centered paradigm?
    Esposito P; Grosjean F; Mangione F; Domenech MV; Rampino T
    Clin Exp Nephrol; 2018 Feb; 22(1):208-209. PubMed ID: 28660444
    [No Abstract]   [Full Text] [Related]  

  • 13. Patterns of IgG subclass deposits in membranous glomerulonephritis in renal allografts.
    Kearney N; Podolak J; Matsumura L; Houghton D; Troxell M
    Transplant Proc; 2011 Dec; 43(10):3743-6. PubMed ID: 22172838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of recurrent, post-kidney transplant membranoproliferative glomerulonephritis with plasmapheresis and rituximab: A case report and literature review
.
    Yango AF; Fischbach BV; Ruiz R; Mudrovich S; Klintmalm G
    Clin Nephrol; 2019 Jan; 91(1):52-58. PubMed ID: 30431428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Beneficial Role Of Anti-Phospholipase A2 Receptor Auto-Antibodies And Rituximab In The Management Of Recurrent Primary Membranous Nephropathy After Kidney Transplantation.
    Anjum N; Nabi Z
    J Ayub Med Coll Abbottabad; 2021; 33(2):315-318. PubMed ID: 34137554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent membranous nephropathy in successive renal transplants.
    Innes A; Woodrow G; Boyd SM; Beckingham IJ; Morgan AG
    Nephrol Dial Transplant; 1994; 9(3):323-5. PubMed ID: 8052443
    [No Abstract]   [Full Text] [Related]  

  • 17. Membranous nephropathy: recurrence after kidney transplantation.
    Marcen R; Mampaso F; Teruel JL; Rivera ME; Orofino L; Navarro-Antolin J; Ortuño J
    Nephrol Dial Transplant; 1996 Jun; 11(6):1129-33. PubMed ID: 8671981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab in post allogeneic hematopoietic stem cell transplantation membranous nephropathy: a case report.
    Vischini G; Cudillo L; Ferrannini M; Di Daniele N; Cerretti R; Arcese W
    J Nephrol; 2009; 22(1):160-3. PubMed ID: 19229832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membranous glomerulonephritis (MGN) in transplanted kidneys: morphologic investigation on 256 renal allografts.
    Monga G; Mazzucco G; Basolo B; Quaranta S; Motta M; Segoloni G; Amoroso A
    Mod Pathol; 1993 May; 6(3):249-58. PubMed ID: 8346172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of noncryoglobulinemic glomerulonephritis with monoclonal Ig deposits: correlation with IgG subclass and response to rituximab.
    Guiard E; Karras A; Plaisier E; Duong Van Huyen JP; Fakhouri F; Rougier JP; Noel LH; Callard P; Delahousse M; Ronco P
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1609-16. PubMed ID: 21700823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.